Backbone modified oligonucleotide analogues

C - Chemistry – Metallurgy – 07 – H

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07H 21/00 (2006.01) A61K 31/52 (2006.01) A61K 31/70 (2006.01) C07D 405/04 (2006.01) C07D 405/14 (2006.01) C07D 473/00 (2006.01) C07F 7/18 (2006.01) C07H 19/04 (2006.01) C07H 19/06 (2006.01) C07H 19/10 (2006.01) C07H 19/16 (2006.01) C07H 23/00 (2006.01)

Patent

CA 2103378

2103378 9220822 PCTABS00017 Therapeutic oligonucleotide analogs which have nuclease resistance and improved cellular uptake are provided. Replacement of posphorodiester inter-sugar linkages found in wild type oligomers with four atom linking groups forms unique di- and polynucleosides and nucleotides useful in regulating RNA expression and in therapeutics. Methods of synthesis and use are also disclosed.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Backbone modified oligonucleotide analogues does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Backbone modified oligonucleotide analogues, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Backbone modified oligonucleotide analogues will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1370469

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.